Saad Kareem's most recent trade in GeneDx Holdings Corp - Ordinary Shares - Class A was a trade of 5,114 Class A Common Stock done . Disclosure was reported to the exchange on March 16, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| GeneDx Holdings Corp - Ord... | Kareem Saad | CHIEF TRANSFORMATION OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2024 | 5,114 | 31,525 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kareem Saad | CHIEF TRANSFORMATION OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2024 | 5,114 | 61,362 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kareem Saad | CHIEF TRANSFORMATION OFFICER | Sale of securities on an exchange or to another person at price $ 10.59 per share. | 16 Mar 2024 | 2,008 | 29,517 | - | 10.6 | 21,269 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kareem Saad | CHIEF TRANSFORMATION OFFICER | Sale of securities on an exchange or to another person at price $ 9.21 per share. | 12 Mar 2024 | 897 | 26,411 | - | 9.2 | 8,261 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kareem Saad | CHIEF TRANSFORMATION OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2024 | 2,841 | 31,249 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kareem Saad | CHIEF TRANSFORMATION OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2024 | 2,841 | 27,308 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Saad Kareem | CHIEF TRANSFORMATION OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jan 2024 | 546 | 2,183 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Saad Kareem | CHIEF TRANSFORMATION OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jan 2024 | 546 | 24,660 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Saad Kareem | CHIEF TRANSFORMATION OFFICER | Sale of securities on an exchange or to another person at price $ 3.24 per share. | 19 Jan 2024 | 193 | 24,467 | - | 3.2 | 625 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kareem Saad | Chief Transformation Officer | Sale of securities on an exchange or to another person at price $ 2.58 per share. | 03 Jan 2024 | 105 | 24,114 | - | 2.6 | 271 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Saad Kareem | Chief Transformation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2024 | 273 | 24,219 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Saad Kareem | Chief Transformation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2024 | 273 | 2,455 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kareem Saad | Chief Transformation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2023 | 5,114 | 25,646 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kareem Saad | Chief Transformation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2023 | 5,114 | 66,476 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kareem Saad | Chief Transformation Officer | Sale of securities on an exchange or to another person at price $ 2.16 per share. | 16 Dec 2023 | 1,700 | 23,946 | - | 2.2 | 3,671 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Saad Kareem | Chief Transformation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2023 | 2,841 | 21,382 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kareem Saad | Chief Transformation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2023 | 2,841 | 34,090 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kareem Saad | Chief Transformation Officer | Sale of securities on an exchange or to another person at price $ 1.61 per share. | 09 Dec 2023 | 850 | 20,532 | - | 1.6 | 1,369 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kareem Saad | Chief Transformation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2023 | 273 | 3,001 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kareem Saad | Chief Transformation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2023 | 273 | 12,142 | - | - | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kareem Saad | Chief Transformation Officer | Sale of securities on an exchange or to another person at price $ 5.99 per share. | 01 Jul 2023 | 83 | 12,059 | - | 6.0 | 497 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kareem Saad | Chief Transformation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2023 | 5,114 | 13,090 | - | - | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kareem Saad | Chief Transformation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2023 | 5,114 | 76,704 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kareem Saad | Chief Transformation Officer | Sale of securities on an exchange or to another person at price $ 6.37 per share. | 16 Jun 2023 | 1,159 | 11,931 | - | 6.4 | 7,383 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kareem Saad | Chief Transformation Officer | Sale of securities on an exchange or to another person at price $ 6.31 per share. | 16 Jun 2023 | 62 | 11,869 | - | 6.3 | 391 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kareem Saad | Chief Transformation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2023 | 2,841 | 8,821 | - | - | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kareem Saad | Chief Transformation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2023 | 2,841 | 39,772 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kareem Saad | Chief Transformation Officer | Sale of securities on an exchange or to another person at price $ 6.49 per share. | 09 Jun 2023 | 845 | 7,976 | - | 6.5 | 5,484 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kareem Saad | Chief Transformation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2023 | 2,700,000 | 2,700,000 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kareem Saad | Chief Transformation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Apr 2023 | 18,014 | 202,673 | - | - | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kareem Saad | Chief Transformation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Apr 2023 | 18,014 | 126,102 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kareem Saad | Chief Transformation Officer | Sale of securities on an exchange or to another person at price $ 0.31 per share. | 19 Apr 2023 | 5,338 | 197,335 | - | 0.3 | 1,659 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kareem Saad | Chief Transformation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2023 | 9,005 | 108,066 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kareem Saad | Chief Transformation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2023 | 9,005 | 187,435 | - | - | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kareem Saad | Chief Transformation Officer | Sale of securities on an exchange or to another person at price $ 0.34 per share. | 01 Apr 2023 | 2,776 | 184,659 | - | 0.3 | 941 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kareem Saad | Chief Transformation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2023 | 93,750 | 1,406,250 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kareem Saad | Chief Transformation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2023 | 93,750 | 213,630 | - | - | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kareem Saad | Chief Transformation Officer | Sale of securities on an exchange or to another person at price $ 0.36 per share. | 09 Mar 2023 | 35,200 | 178,430 | - | 0.4 | 12,665 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kareem Saad | Chief Transformation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jan 2023 | 18,014 | 144,116 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kareem Saad | Chief Transformation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jan 2023 | 18,014 | 119,779 | - | - | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kareem Saad | Chief Transformation Officer | Sale of securities on an exchange or to another person at price $ 0.38 per share. | 19 Jan 2023 | 6,292 | 113,487 | - | 0.4 | 2,417 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kareem Saad | Chief Transformation Officer | Sale of securities on an exchange or to another person at price $ 0.26 per share. | 04 Jan 2023 | 3,170 | 101,765 | - | 0.3 | 832 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kareem Saad | Chief Transformation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2023 | 9,005 | 126,076 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kareem Saad | Chief Transformation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2023 | 9,005 | 104,935 | - | - | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kareem Saad | Chief Transformation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2022 | 1,500,000 | 1,500,000 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kareem Saad | Chief Transformation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Oct 2022 | 18,014 | 101,342 | - | - | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kareem Saad | Chief Transformation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Oct 2022 | 18,014 | 162,130 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kareem Saad | Chief Transformation Officer | Sale of securities on an exchange or to another person at price $ 0.89 per share. | 19 Oct 2022 | 5,412 | 95,930 | - | 0.9 | 4,818 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kareem Saad | Chief Transformation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2022 | 9,005 | 135,081 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kareem Saad | Chief Transformation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2022 | 9,005 | 85,997 | - | - | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kareem Saad | Chief Transformation Officer | Sale of securities on an exchange or to another person at price $ 0.94 per share. | 01 Oct 2022 | 2,669 | 83,328 | - | 0.9 | 2,515 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kareem Saad | Chief Transformation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jul 2022 | 18,014 | 82,303 | - | - | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kareem Saad | Chief Transformation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jul 2022 | 18,014 | 180,144 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kareem Saad | Chief Transformation Officer | Sale of securities on an exchange or to another person at price $ 1.60 per share. | 19 Jul 2022 | 5,311 | 76,992 | - | 1.6 | 8,498 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kareem Saad | Chief Transformation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2022 | 9,005 | 73,294 | - | - | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kareem Saad | Chief Transformation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2022 | 9,005 | 135,081 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kareem Saad | Chief Transformation Officer | Sale of securities on an exchange or to another person at price $ 1.32 per share. | 01 Jul 2022 | 2,612 | 70,682 | - | 1.3 | 3,444 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kareem Saad | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Apr 2022 | 18,014 | 198,158 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kareem Saad | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Apr 2022 | 18,014 | 70,558 | - | - | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kareem Saad | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 2.49 per share. | 19 Apr 2022 | 6,269 | 64,289 | - | 2.5 | 15,610 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kareem Saad | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2022 | 250,150 | 250,150 | - | - | Employee Stock Option (Right to Buy) | |
| GeneDx Holdings Corp - Ord... | Kareem Saad | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2022 | 144,086 | 144,086 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kareem Saad | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 2.84 per share. | 28 Jan 2022 | 6,697 | 52,544 | - | 2.8 | 19,026 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kareem Saad | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2022 | 18,014 | 216,172 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kareem Saad | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2022 | 18,014 | 59,241 | - | - | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kareem Saad | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2021 | 62,875 | 62,875 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kareem Saad | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Oct 2021 | 54,042 | 234,186 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kareem Saad | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Oct 2021 | 54,042 | 54,042 | - | - | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kareem Saad | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 7.54 per share. | 25 Oct 2021 | 16,608 | 37,434 | - | 7.5 | 125,224 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kareem Saad | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 288,228 | 288,228 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kareem Saad | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 192,152 | 192,152 | - | - | Employee Stock Option (Right to Buy) |